Arformoterol
Apararenone[edit | edit source]
Apararenone is a pharmaceutical compound that acts as a mineralocorticoid receptor antagonist. It is primarily used in the treatment of conditions such as hypertension and heart failure. Apararenone works by blocking the action of aldosterone, a hormone that increases the reabsorption of sodium and water in the kidneys, leading to increased blood pressure.
Mechanism of Action[edit | edit source]
Apararenone functions by competitively inhibiting the binding of aldosterone to the mineralocorticoid receptor. This inhibition prevents the activation of the receptor, thereby reducing sodium reabsorption and promoting the excretion of sodium and water. This action helps to lower blood pressure and reduce the workload on the heart.
Clinical Uses[edit | edit source]
Apararenone is used in the management of:
- Hypertension: By reducing blood volume and vascular resistance, apararenone helps to lower blood pressure.
- Heart failure: It helps in reducing the symptoms of heart failure by decreasing fluid overload and improving cardiac function.
Pharmacokinetics[edit | edit source]
Apararenone is administered orally and is absorbed in the gastrointestinal tract. It undergoes hepatic metabolism and is excreted primarily through the kidneys. The pharmacokinetic profile of apararenone allows for once-daily dosing, which can improve patient compliance.
Side Effects[edit | edit source]
Common side effects of apararenone include:
- Hyperkalemia: Due to its potassium-sparing effects, there is a risk of elevated potassium levels in the blood.
- Hypotension: Excessive lowering of blood pressure can occur, especially in patients with pre-existing low blood pressure.
- Dizziness and fatigue: These are common due to the blood pressure-lowering effects.
Contraindications[edit | edit source]
Apararenone should not be used in patients with:
- Severe renal impairment
- Hyperkalemia
- Known hypersensitivity to the drug
Drug Interactions[edit | edit source]
Apararenone can interact with other medications that affect potassium levels, such as ACE inhibitors and potassium supplements. Caution is advised when used concurrently with these agents.
Related Pages[edit | edit source]
Gallery[edit | edit source]
Arformoterol[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD